Q4 2025 Mirion Technologies Inc Earnings Call Transcript
Key Points
- Mirion Technologies Inc (MIR) booked record orders in 2025, totaling over $1 billion, driven by strong performance in the nuclear power market.
- The company achieved double-digit organic revenue growth in both nuclear power (11%) and nuclear medicine (13%) sectors.
- Acquisitions of Certrec and Paragon Energy Solutions have significantly increased Mirion's exposure to the North American nuclear power market.
- Approximately 80% of Mirion's revenue comes from the installed base, which is being incentivized to extend, operate, and modernize, driving demand for Mirion's solutions.
- Mirion's adjusted free cash flow more than doubled in 2025 compared to 2024, reflecting improved earnings and capital structure improvements.
- Mirion's top-line performance was softer than guidance due to weaknesses in the RTQA and labs and research markets.
- The Medical segment faced headwinds in 2025, with nuclear medicine orders down 6% due to tough comps from the previous year.
- The RTQA market experienced sluggishness, particularly in the Japanese market and US healthcare capital spending dynamics.
- Adjusted EPS was slightly below guidance, primarily due to tax dynamics.
- The Paragon acquisition, while strategically beneficial, had a dilutive impact on margins in the short term.
Greetings, and welcome to the Mirion Technologies fourth-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Eric Linn, Treasurer and Head of Investor Relations. Thank you, sir. You may begin.
Okay. Thank you, Melissa. Good morning, and welcome to Mirion's fourth-quarter and full year 2025 earnings conference call. Joining me this morning are Mirion's Founder, Chairman and CEO, Tom Logan; and Mirion's CFO and Medical Group President, Brian Schopfer.
Before we begin today's prepared remarks, allow me to remind you that comments made during this call will include forward-looking statements, and actual results may differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are discussed in our annual reports on Form 10-K, quarterly reports on Form 10-Q and in Mirion's other SEC filings under the caption Risk Factors.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
